Ledger.Open graph →
SEC Form D · filed April 18, 2019

Arrakis Therapeutics, Inc

Offering
$75.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jakob Loven · Waltham, MADirectorNikola Trbovic · Waltham, MADirectorRaj Parekh · Waltham, MADirectorMichael Gilman · CAMBRIDGE, MAExec · DirectorRichard Gaster · Waltham, MADirectorColleen Cuffaro · Waltham, MADirectorNikola Trbovic · Waltham, MADirectorRaj Parekh · Santa Monica, CADirectorMichael Gilman · Belmont, MAExec · DirectorJakob Loven · Waltham, MADirectorRichard Gaster · Waltham, MADirectorColleen Cuffaro · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗